Delivery Order SPE2DB24D1034-SPE2DB24FWAX7
Award Date
7/5/24
Potential Completion Date
7/8/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML pharmaceutical products to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,033.64, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of July 24, 2024 and is not set aside for a specific business type. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other agencies, such...
This federal contract award is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,069.72 firm fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 10, 2024 and was not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,103.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 3, 2025, with a completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the supply of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $4,677.64. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award by the Defense Logistics Agency (DLA) is for the procurement of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product, from the prime contractor Amerisourcebergen Drug Corp. The award, valued at $2,103.96, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The DLA IDC serves as a comprehensive...
This federal contract award is for the pharmaceutical product REPATHA 140 MG/ML SURECLICK, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,248.52 firm-fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICK, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $2,103.96, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through November 2024. No set-aside designation was used for this award. Amerisourcebergen holds a...
This federal contract award, valued at $1,274.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, with a completion date of January 16, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. AmerisourceBergen holds a...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICK ML pharmaceuticals to the Defense Logistics Agency (DLA). The contract, valued at $2,563.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of September 1, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICK pharmaceutical product to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,819.14, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 24, 2024. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 28, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a...